Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
-
Midland Identifies Gold Potential on Its Caniapisc Au Project, James Bay
-
Plato Gold Reports on Third Quarter Results
-
Vislink Reports Third Quarter 2024 Financial and Operational Results
-
HydroGraph Confirms Appointment of Kjirstin Breure as Chief Executive Officer
-
FitLife Brands Announces Third Quarter 2024 Results
-
ZenaTech Announces Revenue Increase of 15% for the Third Quarter Ended September 30th, 2024 and Provides Corporate Highlights
-
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
-
Gaxos Board of Directors Approves Bitcoin as Treasury Reserve Asset
-
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
-
Arbutus to Present at Jefferies London Healthcare Conference
-
Bybit Extends Support to Flood-Devastated Communities in Spain
-
WhiteBIT Launches the Affiliate Program with Bonuses for Participants
-
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
-
Carbon Done Right Provides Strategic Update to Shareholders
-
Rachel Harrington Recognized at the Women of Work Awards
-
Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
WinVest Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date
-
Dorel Reports Third Quarter 2024 Results
-
Mikra Announces Major Sale for Black Friday & Cyber Monday
-
Goodfood Acquires Controlling Interest in Genuine Tea, A Leading Third-Wave Craft Tea Company
-
Reed’s Reports Third Quarter 2024 Results and Provides Business Update
-
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
TransAlta to Acquire Heartland Generation from Energy Capital Partners at a Reduced Price of $542 Million
-
Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjace
-
The Open Source Initiative and the Eclipse Foundation to Collaborate on Shaping Open Source AI (OSAI) Public Policy
-
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
-
Giyani Corporate Update: Demonstration Plant Commissioning Progress Continues
-
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights
-
Aya Gold & Silver Reports Results for Transition Quarter
-
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
-
FlexShopper, Inc. Reports Record 2024 Third-Quarter Financial Results
-
OneWater Marine Inc. Announces Fiscal Fourth Quarter and Full-Year 2024 Results
-
Singing Machine and Stingray Announce Karaoke Microphone Partnership with BYD
-
Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
Boralex reports operating income of $7 million and actively pursues its development and diversification activities in the third quarter
-
Captivision Announces Venture with digiLED and Canary Wharf Group
-
Innovative Mentorship Program Equips English-Speaking Quebecers With Workplace French Skills
-
Next Hydrogen Reports Q3 2024 Financial Results
-
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
-
Sachem Capital Reports Third Quarter 2024 Results – Reports Quarterly Revenues of $14.8 Million
-
Hinge Bio Presents Preclinical Data from its GEM-DIMER™ Programs Targeting B Cell Depletion at the American College of Rheumatology (ACR) Convergence 2024
-
CareerCircle’s Kim Sneeder Named to Staffing Industry Analysts’ 2024 Global Power 150
-
Innventure Reports Third Quarter 2024 Results
-
MiNK Therapeutics Reports Third Quarter 2024 Results and Business Update
-
Aduro Clean Technologies to Present Hydrochemolytic™ Technology as an Innovative Solution for Chemical Recycling at the Advanced Recycling Conference 2024
-
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
-
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting
-
Telesat Reports Results for the Quarter and Nine Months Ended September 30, 2024
-
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
